📊 Score Breakdown
Offering Ability
60
Cash Runway
40
Float Risk
25
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
56%
🔁 Convertible Conversion
60%
• Major convertible overhang: 76% potential dilution
• Convertible risk score very high (85/100)
🔄 Reverse Split
55%
• 50-day avg $0.93 below $1 exchange minimum
📉 Score Deterioration
50%
• Score rose 42 points recently (worsening)
• Score in HIGH risk zone (61/100)
💹 Market Data
Market Cap$24.40M
Shares Outstanding30.15M
Float26.53M
Cash$15.76M
Debt$748.0K
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 2.1% shares (2025Q4 vs prior)
30 institutional holders · 1.02M shares
#1
VANGUARD GROUP INC
499.1K shares
#2
GEODE CAPITAL MANAGEMENT, LLC
141.5K shares
#3
UBS Group AG
60.2K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest2.34M
Days to Cover5.3
% of Float8.8%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2023
424B3
ATM
Apr 17, 2026
EFFECT
EFFECT
Apr 17, 2026
S-1
SHELF
Apr 10, 2026
4
INSIDER TRANSACTION
Apr 03, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for LGVN
📊 LGVN FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 LGVN Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.